Phone: 1-617-401-8149
Fax: 1-617-606-5019
Email: message@sydlabs.com
Or leave a message with a formal purchase
order (PO) Or credit card.
Catalog No. | Product Name | Size | List Price (US$) | Quantity |
---|
The manufacturing conditions of Perjeta / Omnitarg biosimilar from the CHO stable cell line need to be optimized by clients.
The cheapest research grade pertuzumab biosimilar protein (1 mg for >$30) is also available.
Price/availability/specifications subject to change without notice. Unless otherwise indicated, our catalog and customized products are for research use only and not intended for human or animal diagnostic or therapeutic use.
Phone: 1-617-401-8149
Fax: 1-617-606-5019
Email: message@sydlabs.com
Or leave a message with a formal purchase
order (PO) Or credit card.
Pertuzumab (2C4, trade name Perjeta, Omnitarg, Genentech), a humanized monoclonal antibody, inhibits HER dimerization and is used for the treatment of HER2-positive metastatic breast cancer, in combination with trastuzumab and docetaxel. By binding to HER2, Pertuzumab inhibits the dimerization of HER2 with other HER receptors, resulting in slowed tumor growth.
C006: Perjeta / Omnitarg Biosimilar Stable Cell Line (CHO)
The yield of Perjeta / Omnitarg biosimilar from the CHO stable cell line was above 3.0 g/L in a 3 liter manufacturing.
The Perjeta / Omnitarg biosimilar stable cell line alone can be transferred alone or together with the technology of process development and/or antibody purification.
Syd Labs also provides the following anti-ErbB/HER antibody biosimilar stable cell lines:
Herceptin Biosimilar Stable Cell Line (HER2, ErbB-2, c-neu)
Erbitux Biosimilar Stable Cell Line (HER1, ErbB-1, EGFR)
Vectibix Biosimilar Stable Cell Line (HER1, ErbB-1, EGFR)
Copyright © 2009-2022 sydlabs.com. All rights reserved.
Use of this website means that you have read, understood, and accepted the Syd Labs Privacy Policy and Terms & Conditions.